TGFB1 and Alzheimer disease: Additionally, TGF-β is highly expressed in primed MSCs or SRGN-treated MSCs, the signaling pathway associated with TGF-β is impaired in AD [62], and TGF-β itself showed neuroprotective effects [63, 64].